This is the least common treatment method and is usually reserved for young, very active, high-demand patients
Semaglutide and the other GLP-1 agonists have the added benefit of central effects on the hunger centres in the hypothalamus as well as delaying gastric emptying to increase fullness and suppress appetite, a valuable tool for both the treatment of diabetes and weight loss management, but a potential risk for the use of sedation/anaesthesia
Pattern 2: gradual gain of 1 to 2 pounds per week over 4 or more weeks Most likely cause: Calorie creep plus metabolic adaptation
GLP-1s are not recommended during pregnancy, but newer studies show they dont seem to increase the chance of developmental issues (2,7,13)
Additionally, L-carnitine may reduce the symptoms and associated risk factors of type 2 diabetes
Is GLP-Squared a better option than phentermine plus Ozempic